Docusign Form 4 Filings

DOCUSIGN, INC. Chief Legal Officer James P. Shaughnessy reported the vesting and settlement of equity awards into common stock. On March 15, 2026, he exercised restricted stock units and performance stock units that delivered 20966 shares of common stock. To cover tax obligations from these vestings, 9885 shares were withheld by the company, a non-market disposition. After these transactions, Shaughnessy directly holds 65631 shares of DocuSign common stock. The filing reflects routine equity compensation vesting rather than open-market buying or selling.

DocuSign, Inc.’s Chief Financial Officer Blake Jeffrey Grayson reported routine equity compensation activity. On 2026-03-15, he acquired 37,448 shares of common stock through the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs).

To satisfy related tax obligations on these vestings, 15,365 shares of common stock were withheld by DocuSign, a non-market transaction classified as a tax-withholding disposition. After these transactions, Grayson directly owned 133,796 shares of DocuSign common stock.

DOCUSIGN, INC. director Anna Marrs reported a mix of stock-based transactions. On March 5, 2026, she completed an open-market sale of 363 shares of common stock at $46.33 per share, leaving her with 12,251 common shares held directly.

On March 4, 2026, she exercised 725 restricted stock units (RSUs), converting them into an equal number of common shares at $0.00 per share. Each RSU represents a right to receive one share of common stock and vests in twelve equal quarterly installments over three years starting on June 4, 2023, subject to continued service. The filing notes the sale was made under a pre-arranged Rule 10b5-1 trading plan.

DOCUSIGN, INC. director Enrique T. Salem reported an automatic conversion of equity awards rather than an open-market trade. On February 28, 2026, he exercised 729 Restricted Stock Units (RSUs), which converted into 729 shares of common stock at a price of $0.00 per share. After this conversion, his directly held common stock position rose to 166,589 shares.

Each RSU represents the right to receive one share of common stock. The underlying RSU grant has a vest commencement date of May 29, 2025 and vests in equal quarterly installments over one year, with the final installment vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to continued service. The RSUs themselves do not expire.

DocuSign director Teresa Briggs reported the conversion of restricted stock units into common shares. On the reported date, 729 Restricted Stock Units were exercised at a stated price of $0.0000 per unit, resulting in 729 shares of common stock. After this derivative exercise and corresponding acquisition, she directly owned 9,899 shares of DocuSign common stock. Each RSU represents a right to receive one share and, per the disclosure, RSUs vest in equal quarterly installments over one year from a vest commencement date of May 29, 2025, provided she remains a service provider through each vesting date.

DocuSign, Inc. director Irving Blake reported acquiring shares through an equity award. On February 28, 2026, 729 Restricted Stock Units were exercised or converted into 729 shares of common stock at a stated price of $0.00 per share, bringing his direct common stock holdings to 25,364 shares.

Each RSU represents a right to receive one share of common stock. The RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, subject to continued service. The RSUs do not expire and will either vest or be canceled before the vesting date.

DocuSign director Peter Solvik reported an equity award transaction involving restricted stock units. On February 28, 2026, he exercised 729 Restricted Stock Units, which converted into 729 shares of DocuSign common stock at a stated price of $0.00 per share.

After this conversion, Solvik directly held 8,241 shares of common stock. The filing also notes indirect holdings as of that date, including 120,253 shares by a trust, 65,558 shares by children's trusts, 3 shares by a family partnership, and 6,458 shares by his spouse. Each RSU represents a right to receive one share and vests in quarterly installments over one year starting May 29, 2025.

DOCUSIGN, INC. director Mary Agnes Wilderotter acquired 729 shares of common stock through the exercise and conversion of Restricted Stock Units on February 28, 2026 at a price of $0.00 per share. Following this transaction, she directly holds 59,803 common shares.

Each RSU represents a right to receive one share of common stock. These RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, with the final installment vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to her continued service. The RSUs do not expire; they either vest or are canceled before vesting.

DocuSign director James A. Beer reported mixed insider activity. On March 3, 2026, he sold 450 shares of common stock in an open-market trade at $45.02 per share under a pre-arranged Rule 10b5-1 plan. On February 28, 2026, he acquired 729 shares of common stock from the conversion of 729 Restricted Stock Units. Following these transactions, he directly held 14,757 common shares, with an additional 5,543 shares held indirectly by a trust.

DOCUSIGN, INC. director Cain A. Hayes reported an equity award conversion rather than an open-market trade. On February 28, 2026, 729 Restricted Stock Units were exercised at $0.00 per unit, delivering 729 shares of common stock.

Following this transaction, Hayes directly owned 14,988 shares of DocuSign common stock. A separate line shows 729 Restricted Stock Units remaining directly held, each representing a contingent right to receive one share of common stock, subject to the disclosed vesting conditions.

DOCUSIGN, INC. director Michael George Rosenbaum reported the exercise or conversion of restricted stock units into common stock. On March 3, 2026, he exercised 522 restricted stock units at a price of $0.0000 per unit, receiving 522 shares of common stock. After these transactions, he directly held 5,221 restricted stock units and 1,044 shares of common stock. Each RSU represents the right to receive one share of common stock and will vest in twelve equal quarterly installments over three years starting on September 3, 2025, as long as he continues as a service provider.

DOCUSIGN, INC. director Anna Marrs reported mixed share activity. On March 3, 2026, she executed an open-market sale of 365 shares of common stock at $45.02 per share under a pre-arranged Rule 10b5-1 plan, leaving 11,889 shares of common stock directly owned.

On February 28, 2026, 729 Restricted Stock Units (RSUs) were exercised into 729 shares of common stock. Each RSU represents one share, with RSUs scheduled to vest quarterly starting May 29, 2025 over one year, subject to continued service, and they either vest or are canceled rather than expiring.

DocuSign, Inc. director Teresa Briggs reported an open-market sale of common stock. On February 27, 2026, she sold 364 shares at an average price of $44.31 per share under a pre-arranged Rule 10b5-1 trading plan. Following this planned sale, she directly owns 9,170 shares of DocuSign common stock.

DocuSign, Inc. Chief Financial Officer Blake Jeffrey Grayson reported selling 6,500 shares of the company’s common stock on January 9, 2026 at a price of $70 per share. The filing states that the transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person, indicating it was pre-arranged rather than a discretionary trade. After this sale, Grayson directly held 111,713 shares of DocuSign common stock.

DocuSign, Inc. President and CEO Allan C. Thygesen reported planned sales of company common stock. On January 9, 2026, he completed three open-market sales under a Rule 10b5-1 trading plan. The reported transactions were sales of 16,151 shares at $69.35, 9,799 shares at $69.98, and 300 shares at $70.83 per share. Footnotes note that the shares in each trade were sold within stated price ranges and that full price breakdowns are available on request. Following these sales, Thygesen directly beneficially owned 142,261 shares of DocuSign common stock.

DocuSign, Inc. Chief Revenue Officer Paula Hansen reported multiple open-market sales of company common stock. On January 2, 2026, she sold a total of 6,000 shares of DocuSign common stock in four separate transactions, at reported prices of $65.43, $66.94, $67.78, and $68.62 per share.

The filing states that these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted by Hansen, which is designed to allow insiders to sell shares according to a preset schedule. Following the reported sales, Hansen directly beneficially owned 68,970 shares of DocuSign common stock.

Docusign, Inc. reported that its Chief Legal Officer, James P. Shaughnessy, sold common stock in multiple transactions on 01/02/2026. He sold a total of 12,000 shares of Docusign common stock in four separate sales, at prices generally between $64.97 and $68.68, as reflected by the detailed price ranges in the footnotes. These sales were executed pursuant to a Rule 10b5-1 trading plan previously adopted by Shaughnessy. Following the reported transactions, he beneficially owned 54,550 shares of Docusign common stock directly.

DocuSign, Inc. director reported an insider transaction involving company common stock. On 12/10/2025, the reporting person made a transaction coded "G" (a gift) of 15,000 shares of common stock at a stated price of $0, held indirectly through a trust.

After this transaction, the reporting person beneficially owned 120,253 shares of DocuSign common stock indirectly through a trust, in addition to 7,512 shares held directly, 65,558 shares held indirectly by children's trusts, 6,458 shares held indirectly by a spouse, and 3 shares held indirectly through a family partnership.

DocuSign, Inc. Chief Financial Officer, identified as an officer of the company, reported multiple equity transactions in December 2025. On 12/15/2025, the CFO acquired 37,453 shares of common stock at $0 through the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs), and 15,385 shares were withheld to cover tax obligations. Following these transactions, the CFO directly held 127,728 shares of common stock.

On 12/17/2025, the CFO sold 3,525 shares at an average price within a range of $67.31 to $68.29, and 5,990 shares at prices ranging from $68.33 to $69.05, under a pre-established Rule 10b5-1 trading plan. The filing also details ongoing RSU and PSU awards that vest over several years or based on DocuSign’s FY25 subscription revenue and free cash flow performance.

DocuSign's chief legal officer reported multiple stock-based compensation events on December 15, 2025. Several batches of restricted stock units (RSUs) and performance stock units (PSUs) converted into common stock at an exercise price of $0, adding 20,968 shares of common stock.

To cover taxes on these vestings, 9,860 shares were withheld by the company, reducing the net increase in directly held stock. After the reported transactions, the officer directly owned 66,550 shares of DocuSign common stock. The filing also details remaining RSU and PSU awards that continue to vest over time based on service and performance conditions tied to subscription revenue and free cash flow for specified performance periods.

DocuSign, Inc.’s Chief Revenue Officer reported equity award activity involving company stock. On 12/15/2025, the executive acquired 32,515 shares of DocuSign common stock at $0 following the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs). To cover tax obligations triggered by this vesting, 16,513 shares were withheld by the company, also at $0 per share. After these transactions, the officer directly beneficially owned 74,970 shares of common stock. The filing also shows continuing holdings of RSUs and PSUs that may convert into additional shares over time, subject to time-based vesting, performance targets tied to subscription revenue and free cash flow for the FY25 performance period, and continued service conditions.

DocuSign, Inc. reported insider stock activity by its President and General Manager, Growth. On December 15, 2025, the executive sold 1,683 shares of common stock at $70.87 per share under a Rule 10b5-1 trading plan. That same day, vested equity awards were exercised, adding 31,538 shares, and the company withheld 16,019 shares at no price to cover tax obligations from vesting restricted and performance stock units.

On December 17, 2025, the executive completed additional open-market sales of 5,253 shares at an average price of $67.88 and 8,565 shares at an average price of $68.61, with exact prices ranging from $67.31 to $69.05. Following these transactions, the executive directly held 70,197 shares of DocuSign common stock, along with multiple tranches of restricted stock units and performance stock units that may convert into shares over time based on service and performance conditions.

DocuSign, Inc. President and CEO, who also serves as a director, reported equity award activity dated 12/15/2025. The filing shows the exercise and settlement of restricted stock units into 65,561 shares of common stock, with 33,296 shares withheld to cover tax obligations, leaving 168,511 shares of common stock held directly after the transactions.

Multiple grants of restricted stock units and performance stock units remain outstanding, each convertible into common stock at an exercise price of $0. These awards vest over multi‑year schedules, generally in quarterly installments, conditioned on continued service and, for performance stock units, on achieving subscription revenue and free cash flow targets for the FY24 and FY25 performance periods, with potential vesting capped at 200% of target.

DocuSign, Inc. reported that one of its officers, listed as President General Mgr, Growth, sold 983 shares of common stock on 12/11/2025.

The sale was executed at a price of $68.62 per share under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person, and was coded as a sale transaction. After this trade, the officer beneficially owns 70,179 shares of DocuSign common stock, held directly.

Reporting person: Paula Hansen, Chief Revenue Officer at DocuSign, Inc. (DOCU). The filing shows an ESPP purchase and several sales under a Rule 10b5-1 plan. On 10/03/2025 Ms. Hansen acquired 245 shares through the 2018 Employee Stock Purchase Plan at an effective price of $59.27 per share. On 10/07/2025 she sold a total of 6,000 shares in three transactions at weighted prices in the $70.23–$72.80 range, reducing her beneficially owned shares from 64,968 to 58,968. The sales are reported as made pursuant to a Rule 10b5-1 plan and price ranges per tranche are disclosed in the remarks.

DocuSign insider sales: Chief Financial Officer Blake Jeffrey sold a total of 6,500 shares of DOCU on 10/01/2025. The transactions were executed as two separate dispositions: 1,751 shares at prices ranging from $70.09 to $70.97 and 4,749 shares at prices ranging from $71.09 to $71.82. The Form 4 states the sales were effected pursuant to a Rule 10b5-1 trading plan.

After these sales the reporting person beneficially owns 105,660 shares directly. The filing is a routine insider-sale disclosure and does not include any amendments, option exercises, or derivative transactions.

James P. Shaughnessy, Chief Legal Officer of DocuSign, Inc. (DOCU), reported two sales of common stock on 10/01/2025 executed under a Rule 10b5-1 plan. The filing shows a sale of 1,918 shares at prices ranging $70.05–$70.97 (noted as an aggregate price entry of $70.71) leaving 61,024 shares beneficially owned, and a separate sale of 5,582 shares at prices ranging $71.00–$71.75 (aggregate shown as $71.36) leaving 55,442 shares beneficially owned. The transactions total 7,500 shares sold. The Form 4 is signed by an attorney-in-fact and includes statements that full per-price sale breakdowns will be provided upon request.

DocuSign Chief Financial Officer Blake Grayson sold a total of 9,509 shares of DocuSign, Inc. (ticker DOCU) on 09/17/2025 under a pre-established Rule 10b5-1 trading plan. The sales consisted of 5,658 shares at prices ranging from $82.22 to $83.18 and 3,851 shares at prices ranging from $83.20 to $83.65. Following the transactions the reporting person beneficially owned 116,011 shares after the first sale and 112,160 shares after the second sale, reported as direct ownership. The Form 4 was signed by an attorney-in-fact.

Robert Chatwani, an officer (President General Mgr, Growth) of DocuSign, Inc. (DOCU), reported two open-market sales of Common Stock on 09/17/2025 executed under a Rule 10b5-1 plan. The Form 4 shows a sale of 8,215 shares at prices ranging from $82.20 to $83.18, after which the report lists 76,764 shares beneficially owned. A second sale on the same date of 5,602 shares occurred at prices ranging from $83.20 to $83.65, after which the report lists 71,162 shares beneficially owned. The filing was signed by an attorney-in-fact, and the Reporting Person will provide detailed per-price share counts on request.

James A. Beer, a director of DocuSign, reported a sale of 450 shares of the company's common stock at $81.28 per share. After the sale, he is reported to beneficially own 14,199 shares directly and 5,543 shares indirectly through a trust, showing he remains a meaningful stakeholder. The filing notes the sale was effected under a Rule 10b5-1 trading plan, indicating the transaction followed a pre-established arrangement rather than ad hoc trading.

Peter Solvik, a director of DocuSign, filed a Form 4 reporting a sale of 15,000 shares of DocuSign common stock on 09/15/2025 at a price of $81.48 per share. After the reported transaction, the Form 4 shows total beneficial ownership of 135,253 shares, with portions held indirectly by children\'s trusts, a spouse, and a family partnership. The filing is signed on behalf of the reporting person by an attorney-in-fact on 09/17/2025.

James P. Shaughnessy, Chief Legal Officer of DocuSign (DOCU), reported insider transactions dated 09/15/2025. The filing shows 20,966 shares were acquired and 9,841 shares were withheld to satisfy tax obligations, leaving the reporting person with 62,942 total shares after the non-derivative transactions. The Form 4 details multiple restricted stock units (RSUs) and performance stock units (PSUs) that vested or were settled on that date, with specified vesting schedules and performance conditions tied to subscription revenue and free cash flow for FY24 and FY25.

DocuSign, Inc. President and CEO Allan C. Thygesen reported vesting and settlement of restricted and performance stock units on September 15, 2025, converting 65,558 units into common stock at $0.00 per share. 33,295 shares were withheld to cover taxes. He now holds 176,246 common shares, 329,269 restricted stock units and 100,082 performance stock units.

Robert Chatwani, an officer of DocuSign, reported multiple equity transactions on 09/15/2025. The filing shows a sale of 1,682 shares at $80.30 executed pursuant to a Rule 10b5-1 plan and disposition of 16,020 shares withheld by the issuer to satisfy tax obligations upon RSU/PSU vesting. The report also records a non-priced acquisition of 31,538 shares and numerous restricted stock units and performance stock units granted or settled, increasing holdings across several award series. Post-transactions, beneficial ownership figures are shown for each line (for example, 100,999 shares following one reported acquisition). The Form 4 discloses vesting schedules and performance criteria for PSUs and RSUs but does not provide company results or broader financial guidance.

DocuSign CFO Blake Grayson reported multiple equity transactions on 09/15/2025, primarily reflecting the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs). The filing shows 37,449 shares acquired and 15,289 shares withheld to satisfy tax obligations, leaving the reporting person with 136,958 shares after the transactions. Several RSU grants vest over multi‑year schedules (quarterly over four years or front‑loaded schedules) and PSUs vest subject to FY25 subscription revenue and free cash flow performance with a 200% maximum payout, with earned PSUs vesting partially after one year then in quarterly installments. All reported holdings are direct.

Paula Hansen, Chief Revenue Officer of DocuSign, Inc. (DOCU), reported transactions dated 09/15/2025. The filing shows an acquisition of 80,455 shares of common stock and a disposal of 40,857 shares (withholding to satisfy tax obligations), leaving 105,580 and 64,723 shares beneficially owned following those reported non-derivative transactions, respectively. The report also records awards of restricted stock units (RSUs) and performance stock units (PSUs) settled on 09/15/2025, including 63,920 RSUs, 4,033 RSUs, and PSUs of 7,324 and 5,178 units, with resulting beneficial ownership totals shown in the filing. Vesting schedules and performance conditions for these awards are described in the explanatory notes.

Anna Marrs, a Director of DocuSign, Inc. (DOCU), reported a sale of company stock under a pre-established trading plan. On 09/15/2025 she disposed of 728 shares of DocuSign common stock at a reported price of $80.3 per share. After the sale she beneficially owned 10,799 shares, held directly. The filing notes the transaction was effected pursuant to a Rule 10b5-1 plan. The Form 4 was signed by an attorney-in-fact on 09/16/2025.